Experiment 584756
Worktypes
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Serenoa repens (ARECACEAE) |
| Citation | CHAMPAULT,G: PATEL,JC: BONNARD,AM:. (1984). A DOUBLE-BLIND TRIAL OF AN EXTRACT OF THE PLANT SERENOA REPENS IN BENIGN PROSTATIC HYPERPLASIA.. 18() |
| Amount utilized | |
| Compound isolated | |
| Disease | BOTH OBJECTIVE AND SUBJECTIVE SIGNS WERE IMPROVED. THIS IMPROVEMENT WAS SIGNIFICANTLY SUPERIOR TO THAT ACHIEVED WITH PLACEBO. THUS AS PREDICTED BY PHARMACOLOGICAL AND BIOCHEMICAL STUDIES PA109 WOULD THEREFORE APPEAR TO BE USEFUL THERAPEUTIC TOOL IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA. PA109 WAS EXTREMELY WELL TOLERATED WITH LESS SIDE-EFFECTS BEING REPORTED DURING THE STUDY BY PATIENTS RECEIVING PA109(FIVE REPORTS) THAN THOSE RECEIVEING PLACEBO(11 REPORTS). ALL SIDE EFFECTS REPORTED WERE MINOR(E.G.HEADACHE). |
| Dose amount | 320.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |
| Extract | HEXANE EXT |
| Gender | MALE |